Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Consulting agrmnt
Director departure
Appointed director
ANAVEX LIFE SCIENCES CORP. (AVXL) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/24/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/14/2023 8-K Quarterly results
02/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Letter re: Prospectus Supplement"
12/02/2022 8-K Quarterly results
05/27/2022 8-K Quarterly results
04/08/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT"
03/04/2022 8-K Quarterly results
02/04/2022 8-K Quarterly results
02/02/2022 8-K Investor presentation
09/27/2021 8-K Quarterly results
09/13/2021 8-K Quarterly results
06/24/2021 8-K Quarterly results
05/28/2021 8-K Quarterly results
12/28/2020 8-K Quarterly results
Docs: "Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates"
12/15/2020 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Anavex Life Sciences Announces ANAVEX®2-73 Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome"
11/06/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "The Presentation",
"The Presentation"
10/15/2020 8-K Quarterly results
07/02/2020 8-K Quarterly results
05/01/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Sales Agreement, by and among Anavex Life Sciences Corp., Cantor Fitzgerald & Co. and SVB Leerink LLC",
"Opinion by Snell & Wilmer L.L.P",
"Opinion by Snell & Wilmer L.L.P"
04/08/2020 8-K Submission of Matters to a Vote of Security Holders
09/13/2019 8-K Quarterly results
06/12/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Registration Rights Agreement, by and between the Company and Lincoln Park Capital Fund, LLC",
"Opinion of Snell & Wilmer, L.L.P",
"Purchase Agreement, by and between the Company and Lincoln Park Capital Fund, LLC"
04/08/2019 8-K Submission of Matters to a Vote of Security Holders
03/18/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Opinion of Snell & Wilmer, L.L.P"
07/06/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Controlled Equity OfferingSM Sales Agreement, by and between Anavex Life Sciences Corp. and Cantor Fitzgerald & Co",
"Opinion by Snell & Wilmer L.L.P"
04/20/2018 8-K Quarterly results
03/08/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Anavex Life Sciences Strengthens Management Team and Board of Directors"
10/06/2017 8-K Quarterly results
04/21/2017 8-K Form 8-K - Current report
02/13/2017 8-K Form 8-K - Current report
10/21/2016 8-K Form 8-K - Current report
07/22/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated First Amendment to Employment Agreement by and between Anavex Life Sciences Corp. and Christopher Missling, PhD"
07/07/2016 8-K Form 8-K - Current report
06/23/2016 8-K Investor presentation
Docs: "Presentation: ANAVEX 2-73 as a Potential Treatment for Rett Syndrome and Other Pediatric or Infantile Disorders with Seizure Pathology",
"Anavex to Present at the 2016 Rett Syndrome Symposium"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy